Literature DB >> 26909208

Analysis of Tobacco-Specific Nitrosamines in the Common Smokeless Tobacco Afzal in Oman.

Nawal Al-Mukhaini1, Taher Ba-Omar1, Elsadig A Eltayeb1, Aisha A Al-Shehi1.   

Abstract

OBJECTIVES: There is a lack of awareness regarding the carcinogenicity of Afzal, an illegal smokeless tobacco product (STP) widely used among the Omani youth. Previous research has shown that certain types of tobacco-specific nitrosamines (TSNAs) are associated with oral and lung cancers. This study therefore aimed to assess levels of four common TSNAs in a randomly selected sample of Afzal.
METHODS: This study was carried out at Sultan Qaboos University in Muscat, Oman, between April and September 2013. A random sample of Afzal was analysed for four types of TSNAs using high-performance liquid chromatography-tandem mass spectrometry. The four types of TSNAs analysed were 4-(N-nitrosomethylamino)-1-(3-pyridyl)-1-butanone (NNK), N-nitrosonornicotine (NNN), N-nitrosoanatabine (NAT) and N-nitrosoanabasine (NAB). As a reference product, a sample of laboratory-manufactured American moist snuff (Centers for Disease Control and Prevention, Atlanta, Georgia, USA) was also used to confirm the accuracy and precision of the analysis.
RESULTS: The analysis revealed total TSNA levels of 3.573 μg/g in the Afzal sample. Mean levels of NNN, NNK, NAT and NAB were 1.205, 1.015, 0.809 and 0.545 μg/g, respectively.
CONCLUSION: Levels of the two most abundant TSNAs (NNN and NNK) found in the Afzal sample exceeded international regulatory limits. Afzal users therefore need to be educated regarding the potential health risks associated with their STP use. Stricter implementation of current legislation is recommended to reduce the availability and usage of Afzal in Oman.

Entities:  

Keywords:  Carcinogenesis; Liquid Chromatography; Nitrosamines; Oman; Smokeless Tobaccos; Tandem Mass Spectrometry

Year:  2016        PMID: 26909208      PMCID: PMC4746038          DOI: 10.18295/squmj.2016.16.01.005

Source DB:  PubMed          Journal:  Sultan Qaboos Univ Med J        ISSN: 2075-051X


  25 in total

1.  Tobacco habits other than smoking; betel-quid and areca-nut chewing; and some related nitrosamines. IARC Working Group. Lyon, 23-30 October 1984.

Authors: 
Journal:  IARC Monogr Eval Carcinog Risk Chem Hum       Date:  1985-09

2.  Notice regarding requirement for annual submission of the quantity of nicotine contained in smokeless tobacco products manufactured, imported, or packaged in the United States. Centers for Disease Control and Prevention (CDC), Department of Health and Human Services. Notice.

Authors: 
Journal:  Fed Regist       Date:  1999-03-23

3.  Global surveillance of oral tobacco products: total nicotine, unionised nicotine and tobacco-specific N-nitrosamines.

Authors:  Stephen B Stanfill; Gregory N Connolly; Liqin Zhang; Lily T Jia; Jack E Henningfield; Patricia Richter; Tameka S Lawler; Olalekan A Ayo-Yusuf; David L Ashley; Clifford H Watson
Journal:  Tob Control       Date:  2010-11-25       Impact factor: 7.552

4.  Impact of Toombak dipping in the etiology of oral cancer: gender-exclusive hazard in the Sudan.

Authors:  Hussain G Ahmed; Rayan M Mahgoob
Journal:  J Cancer Res Ther       Date:  2007 Apr-Jun       Impact factor: 1.805

5.  Tobacco-specific and betel nut-specific N-nitroso compounds: occurrence in saliva and urine of betel quid chewers and formation in vitro by nitrosation of betel quid.

Authors:  J Nair; H Ohshima; M Friesen; A Croisy; S V Bhide; H Bartsch
Journal:  Carcinogenesis       Date:  1985-02       Impact factor: 4.944

6.  Toombak: a major risk factor for cancer of the oral cavity in Sudan.

Authors:  A M Idris; B Prokopczyk; D Hoffmann
Journal:  Prev Med       Date:  1994-11       Impact factor: 4.018

7.  New and traditional smokeless tobacco: comparison of toxicant and carcinogen levels.

Authors:  Irina Stepanov; Joni Jensen; Dorothy Hatsukami; Stephen S Hecht
Journal:  Nicotine Tob Res       Date:  2008-12       Impact factor: 4.244

8.  Five leading U.S. commercial brands of moist snuff in 1994: assessment of carcinogenic N-nitrosamines.

Authors:  D Hoffmann; M V Djordjevic; J Fan; E Zang; T Glynn; G N Connolly
Journal:  J Natl Cancer Inst       Date:  1995-12-20       Impact factor: 13.506

9.  Effect of storage conditions on nitrosated, acylated, and oxidized pyridine alkaloid derivatives in smokeless tobacco products.

Authors:  R A Andersen; H R Burton; P D Fleming; T R Hamilton-Kemp
Journal:  Cancer Res       Date:  1989-11-01       Impact factor: 12.701

10.  Swedish snus and the GothiaTek® standard.

Authors:  Lars E Rutqvist; Margareta Curvall; Thord Hassler; Tommy Ringberger; Inger Wahlberg
Journal:  Harm Reduct J       Date:  2011-05-16
View more
  4 in total

Review 1.  Regulation of toxic contents of smokeless tobacco products.

Authors:  Amit Kumar; Deeksha Bhartiya; Jasmine Kaur; Suchitra Kumari; Harpreet Singh; Deepika Saraf; Dhirendra Narain Sinha; Ravi Mehrotra
Journal:  Indian J Med Res       Date:  2018-07       Impact factor: 2.375

2.  Comparison of tobacco-specific nitrosamine levels in smokeless tobacco products: High levels in products from Bangladesh.

Authors:  Shamema Nasrin; Gang Chen; Christy J W Watson; Philip Lazarus
Journal:  PLoS One       Date:  2020-05-26       Impact factor: 3.240

Review 3.  Toxic effects of smokeless tobacco on female reproductive health: A review.

Authors:  C Laldinsangi
Journal:  Curr Res Toxicol       Date:  2022-03-07

4.  Global burden of disease due to smokeless tobacco consumption in adults: an updated analysis of data from 127 countries.

Authors:  Kamran Siddiqi; Scheherazade Husain; Aishwarya Vidyasagaran; Anne Readshaw; Masuma Pervin Mishu; Aziz Sheikh
Journal:  BMC Med       Date:  2020-08-12       Impact factor: 8.775

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.